After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Mirum Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Mirum Pharmaceuticals Inc is $2.08B. A total of 0.89 million shares were traded on the day, compared to an average of 371.89K shares.
In the most recent transaction, Radovich Peter sold 1,998 shares of MIRM for 42.82 per share on Jan 07 ’25. After the transaction, the PRESIDENT AND COO now owns 27,015 company shares. In a previous transaction on Jan 07 ’25, Peetz Christopher sold 7,489 shares at 42.82 per share. MIRM shares that CHIEF EXECUTIVE OFFICER owns now total 119,359.
Among the insiders who sold shares, Howe Jolanda disposed of 750 shares on Jan 07 ’25 at a per-share price of $42.82. This resulted in the SVP, GLOBAL CONTROLLER holding 2,926 shares of MIRM after the transaction. In another insider transaction, Howe Jolanda sold 2,500 shares at $47.10 per share on Nov 14 ’24. Company shares held by the SVP, GLOBAL CONTROLLER now total 2,426.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, MIRM has a high of $48.89 and a low of $23.14.
As of this writing, MIRM has an earnings estimate of -$0.25 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.12 per share and a lower estimate of -$0.41.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. MIRM’s latest balance sheet shows that the firm has $156.54M in Cash & Short Term Investments as of fiscal 2021. There were $2.61M in debt and $42.60M in liabilities at the time. Its Book Value Per Share was $4.84, while its Total Shareholder’s Equity was $120.21M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MIRM is Buy with a score of 5.00.
